Viewing Study NCT02263950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:57 PM
Ignite Modification Date: 2026-05-21 @ 7:13 PM
Study NCT ID: NCT02263950
Status: UNKNOWN
Last Update Posted: 2015-09-07
First Post: 2014-10-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours
Sponsor: LondonPharma Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Malignant Neoplasm View
None Artemether View
None Sublingual View
None Neoplastic disease View
None Solid Tumour View
None Anti-cancer drug View
None Chemotherapy View
None LON002 View